LFMD · Nasdaq · ·
US$2.89-1.5%9月29日 收盘
截至 2026年6月30日 的季度,与去年同季度相比。
| 指标 | 截至该日的 3 个月2026年6月30日 | 截至该日的 3 个月2025年6月30日 | 变动 |
|---|---|---|---|
| 营业收入合计 | US$47.3M | US$49M | -3.55% |
| 利润 | -US$7.1M | -US$1.6M | -337.37% |
| 每股收益 | -US$0.16 | -US$0.14 | -14.29% |
| 自由现金流 | -US$7M | US$7.9M | -188.94% |
这些是单季度数字,不是滚动一年——本站其他地方的数字覆盖十二个月,会大得多。季节性业务在两者之间摆动很大:ServiceNow 在十二月季度赚 20 亿美元自由现金流,在六月季度只有 5 亿。
对比对象是去年同一季度,而不是分析师预测。要说“超预期”或“不及预期”需要一致预期数据,那是我们没有的授权数据——而搞错它比不提更糟。
暂无 LifeMD, Inc. 的业绩电话会文字记录。
“Revenue of $47.3 million came in within our guidance range, and while adjusted EBITDA finished below the range we guided to, it improved approximately 21% sequentially. Most importantly, we understand the drivers of the result and have already taken steps to improve performance in the second half. At the same time, the quarter included meaningful progress in reshaping the business around longer-duration members, branded therapies, pharmacy, insurance, and new partnerships. The near-term impact on profitability was greater than we anticipated, but the decisions we made during the quarter are already driving a substantial shift towards what we believe will be higher LTV subscribers,”
逐字引自公告,且只在文件将其归于具名人士时才展示。
公告在收盘后或开盘前发布,因此这里的变动是随后的那个交易日。
Inc. LifeMD ® is a leading virtual care company making high-quality healthcare more accessible, convenient, and affordable. Through its vertically integrated platform, LifeMD connects patients with a 50-state affiliated medical group, laboratory services, a state-of-the-art in-house pharmacy, and a U.S.-based patient care center. Together, these capabilities support care across more than 200 conditions, including primary care, men’s and women’s health, weight management, and hormone therapy.
公司自己的描述,取自公告末尾。
引述和公司简介来自 LifeMD, Inc. 于 2026年8月5日 提交的第 2.02 项 8-K 文件;表格根据其季度报告编制。 在 EDGAR 上阅读公告 股价已按拆股和分红复权。